Hong Kong Connect Flows (Feb 17th): Meituan, Xiaomi, Tencent
We analyzed the Hong Kong Connect Scheme for last week and highlight inflows for Meituan, Xiaomi and outflows from Tencent.
536 Views
CStone Pharmaceuticals Placement (2616.HK) - There Is No Certainty that the Dilemma Will Reverse
CStone's in a reconstruction period after a series of negative news. Its pipeline/business model is hard to bring optimistic outlook. Corporate...
478 Views
Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison.
669 Views
Jiangsu Hengrui Medicine (600276.CH) - About The Performance Recovery and the Concerns Behind
Hengrui's low point was in 2022.Performance will gradually recover due to the ease of negative policy impact.But share price's hard to generate...
676 Views
Legend Biotech Follow-On - A Little Opportunistic. Last Deal Did Well, After a Large Correction
Legend Biotech Corp (LEGN US), a non-wholly owned subsidiary of Hong Kong-listed Genscript Biotech (1548 HK), is planning to raise up to US$250m in...
507 Views